Saturday, May 10, 2014 12:50:12 AM
@lx21: It's Groundhogs Day for $ISR investors. It's the same PR over and over again... $ISR sure makes good use of "Copy/paste"!
@lx21: How special is this conference? This is the 13th conference in 2 years for $ISR. http://t.co/AelxmIHQfg
@lx21: That's 7 times since 2011 that $ISR presented "ground breaking" presentations at a conference http://t.co/3jhAu5LoQM
@lx21: ...another similar $ISR PR (5/7/12): http://t.co/8hAfstM5D2 "A number of presentations, as published in the (cont) http://t.co/w0hOwLvayq
@lx21: ...another similar $ISR PR (10/29/12): http://t.co/ulhlqKDEdG "With six (6) papers being presented at (cont) http://t.co/YN16BZ71ku
@lx21: ...another similar $ISR PR (8/13/13): http://t.co/LSlnrespo8 "With a number of papers being presented at (cont) http://t.co/Xb0zuPxPAa
@lx21: ...another similar $ISR PR (8/13/13): http://t.co/kcg4fv8HrV IsoRay’s Cancer Fighting Cesium-131 Seeds, (cont) http://t.co/6AIA2pdyfg
@lx21: Looks familiar? That PR is from April 2013! Almost word for word identical to the April 2014 PR! (cont) http://t.co/uSFfJm3stT
@lx21: Did everyone read this $ISR PR? Read it again CAREFULLY. http://t.co/004nY55yN1 "IsoRay CEO Dwight Babcock (cont) http://t.co/pIDkgZsCb4
@lx21: How special is this conference? This is the 13th conference in 2 years for $ISR. http://t.co/AelxmIHQfg
@lx21: That's 7 times since 2011 that $ISR presented "ground breaking" presentations at a conference http://t.co/3jhAu5LoQM
@lx21: ...another similar $ISR PR (5/7/12): http://t.co/8hAfstM5D2 "A number of presentations, as published in the (cont) http://t.co/w0hOwLvayq
@lx21: ...another similar $ISR PR (10/29/12): http://t.co/ulhlqKDEdG "With six (6) papers being presented at (cont) http://t.co/YN16BZ71ku
@lx21: ...another similar $ISR PR (8/13/13): http://t.co/LSlnrespo8 "With a number of papers being presented at (cont) http://t.co/Xb0zuPxPAa
@lx21: ...another similar $ISR PR (8/13/13): http://t.co/kcg4fv8HrV IsoRay’s Cancer Fighting Cesium-131 Seeds, (cont) http://t.co/6AIA2pdyfg
@lx21: Looks familiar? That PR is from April 2013! Almost word for word identical to the April 2014 PR! (cont) http://t.co/uSFfJm3stT
@lx21: Did everyone read this $ISR PR? Read it again CAREFULLY. http://t.co/004nY55yN1 "IsoRay CEO Dwight Babcock (cont) http://t.co/pIDkgZsCb4
Recent CATX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:20:15 PM
- Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma • GlobeNewswire Inc. • 05/21/2026 09:51:13 PM
- Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies • GlobeNewswire Inc. • 05/18/2026 10:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 04:47:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:10:44 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results • GlobeNewswire Inc. • 05/11/2026 08:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:43:03 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:23 PM
- Perspective Therapeutics to Provide Several Upcoming Corporate Updates • GlobeNewswire Inc. • 04/24/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 10:05:00 AM
- Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 04/20/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 08:10:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 08:10:05 PM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/02/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:16:31 PM
- Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 08:12:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:36 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results • GlobeNewswire Inc. • 03/16/2026 08:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 12:36:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:24 PM
